Hos patienter disponeret for allergi må beslutningen om at anvende Gadovist træffes efter særlig omhyggelig vurdering af risk- benefit- forholdet.
In patients with an allergic disposition the decision to use Gadovist must be made after particularly careful evaluation of the risk-benefit ratio.